GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy for a form of rare gastrointestinal stromal tumour (GIST). The rumoured ...
Hosted on MSN1mon
Why Pfizer sold its $3 billion stake in HaleonHaleon, known for brands such as Sensodyne, Panadol, and Advil, was created through the merger of GSK and Pfizer’s consumer healthcare businesses in 2019 and spun off as a standalone entity in 2022.
A blank-check company affiliated with drilling company Nabors Industries Ltd. (NYSE: NBR) has found a business to take public ...
GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...
GSK is reportedly in late-stage negotiations ... Approximately 80% of all GIST cases are driven by mutations in the KIT gene. A proposed merger of the UK's Poolbeg with Austrian biotech Hookipa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results